収益サイクル管理市場：製品・サービス（適格性確認、臨床コーディング、CDIソリューション、クレーム処理、否認管理、アウトソーシングサービス）、デリバリー（クラウド）、エンドユーザー（支払者、病院）別 - 2028年までの世界予測

Revenue Cycle Management Market by Product & Services (Eligibility Verification, Clinical Coding, CDI Solutions, Claims Processing, Denial Management, Outsourcing Services), Delivery (Cloud), End Users (Payers, Hospitals) - Global Forecast to 2028

世界の収益サイクル管理市場は、2023年の496億米ドルから2028年には841億米ドルに達すると予測され、予測期間中の年平均成長率は11.1%である。RCM市場は、進化する規制シナリオとコーディング基準の影響を大きく... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年6月30日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	320	336	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界の収益サイクル管理市場は、2023年の496億米ドルから2028年には841億米ドルに達すると予測され、予測期間中の年平均成長率は11.1%である。RCM市場は、進化する規制シナリオとコーディング基準の影響を大きく受けています。ICD 10 Coding Systemは常に更新されている。CMSは、2023年4月1日から有効となる34の新しい手技コードを国際疾病分類に導入した。ICD 10コーディングシステムの新たな更新は、自動化されたRCMプロセスへの依存度を高め、RCM市場の成長にプラスの影響を与えている。しかし、新興国では新しく開発されたRCMソリューションを運用する熟練した従業員が不足しており、RCM市場の成長をある程度妨げる可能性がある。

"アウトソーシングサービス分野は予測期間中に最も高い成長率を示す"
収益サイクル管理市場は、製品とサービスに基づいてソリューションとアウトソーシングサービスに分けられる。収益サイクル管理市場で最もシェアが高いのはアウトソーシングサービス部門である。この分野のシェアが高く、成長率が高いのは、ITインフラの必要性と熟練したHCIT人材の不足に起因している。

"提供形態別では、クラウドベースのセグメントが2022年の収益サイクル管理市場の最大の成長率を占めた。"
世界の収益サイクル管理市場は、提供形態によってオンプレミス型セグメントとクラウド型セグメントに分けられる。収益サイクル管理市場のクラウドベースの配信モードセグメントは大幅な成長率を占めた。クラウドベースの成長率が高いのは、医療システム内でのデータ転送を容易にし、臨床と財務のワークフローを促進する、非常に効率的なクラウドベースのソリューションの利用可能性が高まっているためである。

「エンドユーザー別では、医療機関セグメントが予測期間中に最も高い成長率を示すだろう。
医療費支払者と医療提供者は、エンドユーザーに基づく世界の収益サイクル管理市場の2つのセグメントです。収益サイクル管理市場で最もシェアが高いのは医療提供者部門である。このセクターの市場シェアが大きいのは、患者登録から請求・請求処理に至るまで、あらゆる領域で自動化に対する需要が高まっていること、また、医療提供者組織の全体的な財務健全性を高める透明性が強化されていることに起因している。

「中東・アフリカ市場は、予測期間中（2021～2028年）に最も高い成長率を示すと予測される。
2022年、中東・アフリカ市場は予測期間中最高のCAGRで発展すると予測される。eヘルスを奨励する政府の試み、増え続ける医療ツーリズム、認知度の向上、質の高い医療へのニーズの高まりなどが、この地域の市場急成長の要因となっている。

本レポートで参照した主な参加企業の内訳は以下の通りである：
- 企業タイプ別（供給側）：ティア1：40％、ティア2：35％、ティア3：25
- 役職別Cレベル：25％、ディレクターレベル：55％、その他：20
- 地域別北米：40％、アジア太平洋地域：25％、ヨーロッパ：20％、ラテンアメリカ：10％、中東・アフリカ：5
収益サイクル管理市場の主要企業
R1 RCM（米国）、オラクル（米国）、オプタム（米国）が市場の主要プレーヤーである。その他のプレーヤーとしては、McKesson Corporation（米国）、Change Healthcare（米国）、3M（米国）、Experian plc（アイルランド）、Conifer Health Solutions（米国）、Veradigm（米国）、GE Healthcare（米国）、Cognizant（米国）、athenahealth（米国）、SSI Group LLC（米国）、AdvantEdge Healthcare（米国）、Huron Consulting Group（米国）などが挙げられる。
調査範囲
当レポートでは、収益サイクル管理市場を分析し、製品＆サービス、提供形態、エンドユーザー、地域などの様々なセグメントに基づいて、市場規模と今後の成長可能性を推計することを目的としています。また、同市場における主要企業の競合分析、企業プロフィール、提供製品、最新動向、主要市場戦略も掲載しています。

レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業にとっても、市場の動向を把握するのに役立ちます。本レポートを購入される企業は、以下の5つの戦略を1つ、または組み合わせて使用することができます。

本レポートは、以下のポイントに関する洞察を提供する：
- 主な推進要因の分析（RCMソリューションの採用を後押しする規制要件と政府のイニシアティブの高まり、患者数の増加とそれに伴う医療保険の伸び、請求ミスや償還額の減少による収益の損失、非構造化医療データの管理ニーズの高まり、医療における強固なプロセス改善に対する需要の高まり）、収益サイクル管理市場（RCM）の成長に影響を与える阻害要因（低開発国や発展途上国におけるITインフラの制約、導入コストの高さ）、機会（発展途上国におけるアウトソーシングサービスの増加、AIやクラウドベースの導入に対する需要の高まり）、課題（データのセキュリティや機密性に関する問題、従来手法からの切り替えに対する消極性）。
- 製品開発/イノベーション：収益サイクル管理市場における今後の技術、研究開発活動、製品発売に関する詳細な洞察。
- 市場開発：有利な新興市場に関する包括的な情報。地域別に様々なタイプの収益サイクル管理ソリューションの市場を分析しています。
- 市場の多様化：収益サイクル管理市場における製品、未開拓地域、最近の開発、投資に関する情報を網羅。
- 競合評価：収益サイクル管理市場における主要企業の市場シェア、戦略、製品、流通ネットワーク、製造能力を詳細に評価します。

ページTOPに戻る

1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.3 MARKET SCOPE 40
1.3.1 INCLUSIONS AND EXCLUSIONS 40
1.3.2 MARKETS COVERED 40
1.3.3 REGIONS COVERED 41
1.3.4 YEARS CONSIDERED 41
1.4 CURRENCY CONSIDERED 41
1.5 STAKEHOLDERS 42
1.6 LIMITATIONS 42
1.7 SUMMARY OF CHANGES 42
1.8 IMPACT OF RECESSION 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 1 RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 Key data from secondary sources 45
2.1.2 PRIMARY DATA 46
FIGURE 2 PRIMARY SOURCES 46
2.1.2.1 Key data from primary sources 47
2.1.2.2 Insights from primary experts 48
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 48
2.2 MARKET SIZE ESTIMATION: REVENUE CYCLE MANAGEMENT MARKET 49
FIGURE 4 MARKET SIZE ESTIMATION 50
FIGURE 5 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
FIGURE 6 CAGR PROJECTIONS: OVERALL REVENUE CYCLE MANAGEMENT MARKET 52
2.2.1 TOP-DOWN APPROACH 53
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 54
FIGURE 7 DATA TRIANGULATION METHODOLOGY 54
2.4 MARKET RANKING ANALYSIS 55
2.5 RESEARCH ASSUMPTIONS 55
2.6 RISK ASSESSMENT 56
TABLE 1 RISK ASSESSMENT: REVENUE CYCLE MANAGEMENT MARKET 56
2.7 RESEARCH LIMITATIONS 56
2.7.1 METHODOLOGY-RELATED LIMITATIONS 56
2.7.2 SCOPE-RELATED LIMITATIONS 56
2.8 IMPACT OF RECESSION ON REVENUE CYCLE MANAGEMENT MARKET 57
3 EXECUTIVE SUMMARY 58
FIGURE 8 REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 58
FIGURE 9 REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 10 REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 59
FIGURE 11 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 60
4 PREMIUM INSIGHTS 61
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN REVENUE CYCLE MANAGEMENT MARKET 61
FIGURE 12 GROWING REGULATORY REQUIREMENTS AND GOVERNMENT INITIATIVES TO DRIVE MARKET 61
4.2 REVENUE CYCLE MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 62
FIGURE 13 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 62
4.3 REGIONAL MIX: REVENUE CYCLE MANAGEMENT MARKET (2021–2028) 63
FIGURE 14 MIDDLE EAST & AFRICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 63
4.4 REVENUE CYCLE MANAGEMENT MARKET: DEVELOPED VS. EMERGING ECONOMIES, 2023 VS. 2028 (USD MILLION) 63
FIGURE 15 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
TABLE 2 REVENUE CYCLE MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
5.2.1 DRIVERS 65
5.2.1.1 Growing regulatory requirements and government initiatives 65
5.2.1.2 Increasing patient volume and subsequent growth in health insurance 66
5.2.1.3 Loss of revenue due to billing errors and declining reimbursements 66
5.2.1.4 Growing need to manage unstructured healthcare data 67
5.2.1.5 Rising demand for robust process improvements in healthcare sector 67
5.2.2 RESTRAINTS 68
5.2.2.1 High deployment costs 68
5.2.2.2 IT infrastructural constraints in emerging economies 68
5.2.3 OPPORTUNITIES 69
5.2.3.1 Increasing outsourcing services in emerging economies 69
5.2.3.2 Growing demand for AI and cloud-based deployment 70
5.2.4 CHALLENGES 71
5.2.4.1 Issues related to data security and confidentiality 71
5.2.4.2 Reluctance to switch from conventional methods 71
6 INDUSTRY TRENDS 72
6.1 GREATER FOCUS ON PATIENT FINANCIAL EXPERIENCE 72
6.2 USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 72
6.3 PIVOTAL ROLE OF DATA ANALYSIS IN MANAGING HEALTHCARE REVENUE CYCLES 72
6.4 INCREASING NUMBER OF PARTNERSHIPS AND COLLABORATIONS TO DRIVE INNOVATION 73
6.4.1 TECHNOLOGY ANALYSIS 73
6.5 PORTER’S FIVE FORCES ANALYSIS 74
FIGURE 16 REVENUE CYCLE MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 75
TABLE 3 REVENUE CYCLE MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 75
6.5.1 INTENSITY OF COMPETITIVE RIVALRY 76
6.5.2 BARGAINING POWER OF SUPPLIERS 76
6.5.3 BARGAINING POWER OF BUYERS 76
6.5.4 THREAT OF NEW ENTRANTS 76
6.5.5 THREAT OF SUBSTITUTES 76
6.6 REGULATORY LANDSCAPE 77
6.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 7 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 8 REVENUE CYCLE MANAGEMENT MARKET: REGULATORY STANDARDS 80
6.7 VALUE CHAIN ANALYSIS 80
FIGURE 17 VALUE CHAIN ANALYSIS (2022) 81
6.8 ECOSYSTEM/MARKET MAP 81
FIGURE 18 REVENUE CYCLE MANAGEMENT MARKET: ECOSYSTEM 81
6.9 PATENT ANALYSIS 82
FIGURE 19 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO JUNE 2023 82
FIGURE 20 TOP REVENUE CYCLE MANAGEMENT PATENT OWNERS 82
TABLE 9 KEY PATENTS IN REVENUE CYCLE MANAGEMENT MARKET (2020–2023) 83
6.10 ADJACENT MARKET ANALYSIS 84
FIGURE 21 POPULATION HEALTH MANAGEMENT MARKET: MARKET OVERVIEW 84
FIGURE 22 HEALTHCARE ANALYTICS MARKET: MARKET OVERVIEW 85
6.11 CASE STUDY ANALYSIS 85
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 86
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 86
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 86
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 87
6.12.2 BUYING CRITERIA 87
FIGURE 24 KEY BUYING CRITERIA FOR REVENUE CYCLE MANAGEMENT COMPONENTS 87
TABLE 11 KEY BUYING CRITERIA FOR REVENUE CYCLE MANAGEMENT COMPONENTS 87
6.13 KEY CONFERENCES AND EVENTS IN 2023–2024 88
TABLE 12 REVENUE CYCLE MANAGEMENT MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 88
6.14 PRICING ANALYSIS 88
6.15 TRENDS/DISRUPTIONS IMPACTING BUYERS 89
FIGURE 25 REVENUE CYCLE MANAGEMENT MARKET: TRENDS/DISRUPTIONS IMPACTING BUYERS 89
7 REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE 90
7.1 INTRODUCTION 91
TABLE 13 REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 91
7.2 SOLUTIONS 91
TABLE 14 SOLUTIONS OFFERED BY KEY MARKET PLAYERS 92
TABLE 15 SOLUTIONS: REVENUE CYCLE MANAGEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 92
7.2.1 PATIENT ACCESS SOLUTIONS 93
TABLE 16 PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 17 PATIENT ACCESS SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 94
7.2.1.1 Eligibility verification solutions 94
7.2.1.1.1 Eligibility verification solutions segment to account for largest share of patient access solutions market 94
TABLE 18 ELIGIBILITY VERIFICATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 95
TABLE 19 ELIGIBILITY VERIFICATION SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 96
7.2.1.2 Pre-certification & authorization solutions 96
7.2.1.2.1 Electronic pre-certification and authorization help reduce error risks 96
TABLE 20 PRE-CERTIFICATION & AUTHORIZATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 97
TABLE 21 PRE-CERTIFICATION & AUTHORIZATION SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 97
7.2.1.3 Other patient access solutions 98
TABLE 22 OTHER PATIENT ACCESS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 98
TABLE 23 OTHER PATIENT ACCESS SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 99
7.2.2 MID-REVENUE CYCLE SOLUTIONS 99
TABLE 24 MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 25 MID-REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 100
7.2.2.1 Clinical coding solutions 101
7.2.2.1.1 Increasing complexity of medical codes to drive market 101
TABLE 26 CLINICAL CODING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 101
TABLE 27 CLINICAL CODING SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 102
7.2.2.2 Clinical documentation improvement solutions 102
7.2.2.2.1 Automated feedback and guidance by CDI solutions help physicians improve accuracy of patient records 102
TABLE 28 CLINICAL DOCUMENTATION IMPROVEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 103
TABLE 29 CLINICAL DOCUMENTATION IMPROVEMENT SOLUTIONS MARKET, BY COUNTRY/ REGION, 2021–2028 (USD MILLION) 103
7.2.2.3 Other mid-revenue cycle solutions 104
TABLE 30 OTHER MID-REVENUE CYCLE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 104
TABLE 31 OTHER MID-REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 104
7.2.3 BACK-END REVENUE CYCLE SOLUTIONS 105
TABLE 32 BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 33 BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 106
7.2.3.1 Claims processing solutions 106
7.2.3.1.1 Claims processing solutions help reduce false claims and manual effort 106
TABLE 34 CLAIMS PROCESSING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 107
TABLE 35 CLAIMS PROCESSING SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 107
7.2.3.2 Denial management solutions 108
7.2.3.2.1 Denial management solutions help healthcare payers and providers with effective claims management 108
TABLE 36 DENIAL MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 108
TABLE 37 DENIAL MANAGEMENT SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 109
7.2.3.3 Other back-end revenue cycle solutions 109
TABLE 38 OTHER BACK-END REVENUE CYCLE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 109
TABLE 39 OTHER BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 110
7.3 OUTSOURCING SERVICES 111
TABLE 40 OUTSOURCING SERVICES: REVENUE CYCLE MANAGEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 41 OUTSOURCING SERVICES: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY/REGION, 2021–2028(USD MILLION) 112
7.3.1 PATIENT ACCESS OUTSOURCING SERVICES 112
7.3.1.1 Patient access outsourcing services segment to account for largest share of outsourcing services market 112
TABLE 42 PATIENT ACCESS OUTSOURCING SERVICES OFFERED BY KEY MARKET PLAYERS 113
TABLE 43 PATIENT ACCESS OUTSOURCING SERVICES MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 114
7.3.2 MID-REVENUE CYCLE OUTSOURCING SERVICES 114
7.3.2.1 Increasing losses due to billing errors, scarcity of IT professionals, and infrastructure limitations to drive market 114
TABLE 44 MID-REVENUE CYCLE OUTSOURCING SERVICES OFFERED BY KEY MARKET PLAYERS 115
TABLE 45 MID-REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 115
7.3.3 BACK-END REVENUE CYCLE OUTSOURCING SERVICES 116
7.3.3.1 Shortage of skilled HCIT professionals to drive market 116
TABLE 46 BACK-END REVENUE CYCLE OUTSOURCING SERVICES OFFERED BY KEY MARKET PLAYERS 116
TABLE 47 BACK-END REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 117
8 REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE 118
8.1 INTRODUCTION 119
TABLE 48 REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 119
8.2 ON-PREMISES SOLUTIONS 119
8.2.1 ABILITY TO REUSE EXISTING SERVERS AND STORAGE HARDWARE TO DRIVE DEMAND FOR ON-PREMISES SOLUTIONS 119
TABLE 49 ON-PREMISES SOLUTIONS: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 120
8.3 CLOUD-BASED SOLUTIONS 120
8.3.1 DEMAND FOR AFFORDABLE CLOUD-BASED REVENUE CYCLE MANAGEMENT SOLUTIONS FROM SMALL AND MEDIUM-SIZED HEALTHCARE FACILITIES TO DRIVE MARKET 120
TABLE 50 CLOUD-BASED SOLUTIONS: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 121
9 REVENUE CYCLE MANAGEMENT MARKET, BY END USER 122
9.1 INTRODUCTION 123
TABLE 51 REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 123
9.2 HEALTHCARE PROVIDERS 123
TABLE 52 REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 53 REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 124
9.2.1 INPATIENT FACILITIES 125
TABLE 54 REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 55 REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 126
9.2.1.1 Hospitals 126
9.2.1.1.1 Growing need to improve profitability in healthcare operations to drive adoption of RCM tools in hospitals 126
TABLE 56 REVENUE CYCLE MANAGEMENT MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 127
9.2.1.2 Other inpatient facilities 127
TABLE 57 REVENUE CYCLE MANAGEMENT MARKET FOR OTHER INPATIENT FACILITIES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 128
9.2.2 OUTPATIENT FACILITIES 128
TABLE 58 REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 59 REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 129
9.2.2.1 Physician practices 130
9.2.2.1.1 High demand for integration of EHR with practice management systems among physician practices 130
TABLE 60 REVENUE CYCLE MANAGEMENT MARKET FOR PHYSICIAN PRACTICES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 130
9.2.2.2 Ambulatory surgical centers (ASCs) 131
9.2.2.2.1 Eroding patient volumes at hospitals due to high infection rate of COVID-19 to drive demand for ASCs 131
TABLE 61 REVENUE CYCLE MANAGEMENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 131
9.2.2.3 Hospital outpatient facilities 132
9.2.2.3.1 Need to maintain documentation for high volume of patients in hospital OPDs to drive demand for RCM solutions 132
TABLE 62 REVENUE CYCLE MANAGEMENT MARKET FOR HOSPITAL OUTPATIENT FACILITIES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 132
9.2.2.4 Diagnostic & imaging centers 133
9.2.2.4.1 Growing preference of patients for shorter waiting times & technologically advanced specialty clinics to drive demand for diagnostic & imaging centers 133
TABLE 63 REVENUE CYCLE MANAGEMENT MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 133
9.2.2.5 Other outpatient facilities 134
TABLE 64 REVENUE CYCLE MANAGEMENT MARKET FOR OTHER OUTPATIENT FACILITIES, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 134
9.3 HEALTHCARE PAYERS 135
9.3.1 INCREASING PRODUCTIVITY AND PROFITABILITY OF CODING OPERATIONS TO DRIVE ADOPTION OF RCM SOLUTIONS BY HEALTHCARE PAYERS 135
TABLE 65 REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 135
10 REVENUE CYCLE MANAGEMENT MARKET, BY REGION 136
10.1 INTRODUCTION 137
TABLE 66 REVENUE CYCLE MANAGEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 137
10.2 NORTH AMERICA 137
FIGURE 26 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET SNAPSHOT 138
TABLE 67 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 68 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 139
TABLE 69 NORTH AMERICA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 70 NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 71 NORTH AMERICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 72 NORTH AMERICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 73 NORTH AMERICA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 74 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 142
TABLE 75 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 143
TABLE 76 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 77 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 78 NORTH AMERICA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 144
10.2.1 US 144
10.2.1.1 Growing focus of healthcare providers on improving care quality and reducing medical errors & healthcare expenses to drive market 144
TABLE 79 US: KEY MACRO INDICATORS 145
TABLE 80 US: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 145
TABLE 81 US: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 82 US: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 83 US: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 84 US: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 85 US: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 86 US: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 148
TABLE 87 US: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 149
TABLE 88 US: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 89 US: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 90 US: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 150
10.2.2 CANADA 150
10.2.2.1 Need for healthcare cost containment and financial management of healthcare organizations to support market growth 150
TABLE 91 CANADA: KEY MACRO INDICATORS 151
TABLE 92 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 151
TABLE 93 CANADA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 94 CANADA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 95 CANADA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 96 CANADA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 97 CANADA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 98 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 154
TABLE 99 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 154
TABLE 100 CANADA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 101 CANADA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 102 CANADA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 155
10.3 EUROPE 155
TABLE 103 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 104 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 157
TABLE 105 EUROPE: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 106 EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 107 EUROPE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 108 EUROPE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 109 EUROPE: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 110 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 160
TABLE 111 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 160
TABLE 112 EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 113 EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 114 EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 161
10.3.1 GERMANY 161
10.3.1.1 Increasing patient volume to boost adoption of RCM solutions 161
TABLE 115 GERMANY: KEY MACRO INDICATORS 162
TABLE 116 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 162
TABLE 117 GERMANY: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 118 GERMANY: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 119 GERMANY: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 120 GERMANY: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 121 GERMANY: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 122 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 165
TABLE 123 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 165
TABLE 124 GERMANY: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 125 GERMANY: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 126 GERMANY: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 167
10.3.2 FRANCE 167
10.3.2.1 Government investments to increase demand for effective RCM solutions 167
TABLE 127 FRANCE: KEY MACRO INDICATORS 168
TABLE 128 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 168
TABLE 129 FRANCE: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 130 FRANCE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 131 FRANCE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 132 FRANCE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 133 FRANCE: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 134 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 171
TABLE 135 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 171
TABLE 136 FRANCE: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 137 FRANCE: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 138 FRANCE: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 172
10.3.3 UK 172
10.3.3.1 Growing patient pool to boost demand for RCM solutions & services 172
TABLE 139 UK: KEY MACRO INDICATORS 173
TABLE 140 UK: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 173
TABLE 141 UK: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 142 UK: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 143 UK: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 144 UK: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 145 UK: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 146 UK: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 176
TABLE 147 UK: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 176
TABLE 148 UK: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 149 UK: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 150 UK: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 178
10.3.4 ITALY 178
10.3.4.1 Initiatives toward digitalizing patient records to drive market 178
TABLE 151 ITALY: KEY MACRO INDICATORS 179
TABLE 152 ITALY: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 179
TABLE 153 ITALY: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 154 ITALY: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 155 ITALY: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 156 ITALY: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 157 ITALY: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 158 ITALY: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 181
TABLE 159 ITALY: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 160 ITALY: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 161 ITALY: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 183
10.3.5 SPAIN 183
10.3.5.1 IT infrastructural improvements to boost market 183
TABLE 162 SPAIN: KEY MACRO INDICATORS 184
TABLE 163 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 184
TABLE 164 SPAIN: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 165 SPAIN: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 166 SPAIN: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 167 SPAIN: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 168 SPAIN: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 169 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 187
TABLE 170 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 187
TABLE 171 SPAIN: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 172 SPAIN: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 173 SPAIN: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 188
10.3.6 REST OF EUROPE 188
TABLE 174 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 189
TABLE 175 REST OF EUROPE: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 176 REST OF EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 177 REST OF EUROPE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 178 REST OF EUROPE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 179 REST OF EUROPE: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 180 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 192
TABLE 181 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 192
TABLE 182 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 183 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 184 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 193
10.4 ASIA PACIFIC 193
FIGURE 27 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET SNAPSHOT 194
TABLE 185 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 186 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 195
TABLE 187 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 188 ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 189 ASIA PACIFIC: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 190 ASIA PACIFIC: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 191 ASIA PACIFIC: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 192 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 198
TABLE 193 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 198
TABLE 194 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 195 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 196 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 200
10.4.1 JAPAN 200
10.4.1.1 Government mandates to boost adoption of RCM solutions 200
TABLE 197 JAPAN: KEY MACRO INDICATORS 201
TABLE 198 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 201
TABLE 199 JAPAN: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 200 JAPAN: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 201 JAPAN: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 202 JAPAN: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 203 JAPAN: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 204 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 204
TABLE 205 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 204
TABLE 206 JAPAN: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 207 JAPAN: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 208 JAPAN: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE 2021–2028 (USD MILLION) 205
10.4.2 CHINA 205
10.4.2.1 Digitalization and improving infrastructure to support market growth 205
TABLE 209 CHINA: KEY MACRO INDICATORS 206
TABLE 210 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 206
TABLE 211 CHINA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 212 CHINA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 213 CHINA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 214 CHINA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 215 CHINA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 216 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 209
TABLE 217 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 210
TABLE 218 CHINA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 219 CHINA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 220 CHINA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE 2021–2028 (USD MILLION) 211
10.4.3 INDIA 211
10.4.3.1 Growing patient pool to support market growth 211
TABLE 221 INDIA: KEY MACRO INDICATORS 212
TABLE 222 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 212
TABLE 223 INDIA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 224 INDIA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 225 INDIA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 226 INDIA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 227 INDIA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 228 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 215
TABLE 229 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 215
TABLE 230 INDIA: REVENUE CYCLE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 231 INDIA: REVENUE CYCLE MANAGEMENT MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 232 INDIA: REVENUE CYCLE MANAGEMENT MARKET FOR OUTPATIENT FACILITIES, BY TYPE 2021–2028 (USD MILLION) 217

ページTOPに戻る

Table of Contents

Summary

The global revenue cycle management market is projected to reach USD 84.1 billion by 2028 from USD 49.6 billion in 2023, at a CAGR of 11.1% during the forecast period. The RCM market is heavily influenced by evolving regulatory scenarios and coding standards. There have been constant updates in the ICD 10 Coding System. CMS has introduced 34 new procedure codes into the International Classification of Diseases, which are effective from April 01, 2023. New updates in ICD 10 coding systems subsequently increase dependencies on the automated RCM process, which has positively impacted the RCM market growth. However, emerging countries experience a shortage of skilled employees for operating the newly developed RCM solutions, which might hamper the RCM market growth to a certain extent.

“The outsourcing services segment will grow at the highest rate during the forecast period.”
The revenue cycle management market has been divided into solutions and outsourcing services based on products and services. The revenue cycle management market’s highest share belonged to the outsourcing services category. This segment’s large share and high growth can be attributed to the need for IT infrastructure and the shortage of skilled HCIT personnel.

“By delivery mode, the cloud-based segment accounted for the largest growth rate of revenue cycle management market in 2022.”
The global revenue cycle management market is divided into on-premise and cloud-based segments based on delivery mode. The revenue cycle management market’s cloud-based delivery mode segment accounted for a substantial growth rate. The high growth rate of cloud-based segment can be attributed to the growing availability of highly efficient cloud-based solutions offering easy data transfer within healthcare systems, facilitating clinical and financial workflows.

“By end-user, the healthcare providers segment will grow at the highest rate during the forecast period.”
Healthcare payers and providers are the two segments of the global revenue cycle management market based on end users. The Revenue cycle management market's highest share belonged to the healthcare providers sector. The significant market share of this sector can be ascribed to the increased demand for automation in all areas, from patient registration to billing and claims processing, and to enhanced transparency that enhances the provider organization’s overall financial health.

“The market in Middle East & Africa is projected to witness the highest growth rate during the forecast period (2021–2028).”
In 2022, the Middle East & Africa market is anticipated to develop at the highest CAGR during the forecast period. Government attempts to encourage eHealth, ever-increasing medical tourism, increased awareness, and the growing need for high-quality healthcare are all responsible for the region’s market’s rapid rise.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type (Supply-side): Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation: C-level: 25%, Director-level: 55%, and Others: 20%
• By Region: North America: 40%, Asia-Pacific: 25%, Europe: 20%, Latin America: 10%, and Middle East & Africa: 5%
Key Players in the Revenue Cycle Management Market
R1 RCM (US), Oracle (US), Optum (US) are the leading players in the market. Other players include McKesson Corporation (US), Change Healthcare (US), 3M (US), Experian plc (Ireland), Conifer Health Solutions (US), Veradigm (US), GE Healthcare (US), Cognizant (US), athenahealth (US), SSI Group LLC (US), AdvantEdge Healthcare (US), and Huron Consulting Group (US)
Research Coverage:
The report analyzes the revenue cycle management market and aims at estimating the market size and future growth potential of this market based on various segments such as product & services, delivery mode, end user, and region. The report also includes competitive analysis of the key players in this market, their company profiles, products offered, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:
• Analysis of key drivers (growing regulatory requirements & government initiatives to boost the adoption of RCM Solutions, increasing patient volume and subsequent growth in health insurance, loss of revenue due to billing errors and declining reimbursements, Growing need to manage unstructured healthcare data, rising demand for robust process improvements in healthcare), restraints (IT infrastructural constraints in underdeveloped and developing countries, high deployment costs), opportunities (increasing outsourcing services in developing countries, growing demand for AI & cloud-based deployment), and challenges (issues related to data security and confidentiality, reluctance to switch from conventional methods) influencing the growth of revenue cycle management market (RCM).
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the revenue cycle management market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of revenue cycle management solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the revenue cycle management market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the revenue cycle management market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（hospitals）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（hospitals）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?